Knowledge for Growth – May 30th – Gent, Belgium

Apitope presents at The Therapeutic & Preventative Vaccines for Autoimmune diseases

Apitope International N.V., the biopharmaceutical company developing peptide therapies for autoimmune diseases, is pleased to announce that Dr. Keith Martin, CEO, will provide an update on Apitope (antigen processing independent epitope autoimmune vaccines) at the symposium on “Therapeutic & Preventative Vaccines for Autoimmune Diseases: Scientific & Commercial Opportunities”, sponsored by the Juvenile Diabetes Research Foundation and Fast Forward, LLC.

Dr. Martin will present at the Hilton San Francisco, Union Square, at 2.45pm (PST) on Sunday, 9 January 2011, prior to the J.P. Morgan Healthcare Conference.

The symposium will feature leading researchers and experts on autoimmune vaccines, presenting the latest scientific and technological knowledge and insight into this emerging field.

Apitope presents at BioEquity Europe Conference 19th May 2010

Apitope International N.V., the autoimmune peptide therapy company, announces today that Dr. Keith Martin, CEO,will give an overview of the Company’s business at ‘BioEquity Europe 2010’.

The presentation will be at the Swissôtel Zurich, Switzerland at 15.30 (CET) on Wednesday, 19 May 2010.

The presentation will focus on Apitope’s development of therapeutic peptides for revolutionary treatment of autoimmune diseases and allergies.

Apitope presenting at the Peptide Conference 30th March 2010

Apitope International N.V., the autoimmune peptide therapy company, announced today that Dr. Keith Martin, CEO, will give an overview of the Company’s business at ‘The Peptide Conference’. The presentation will be at The Wellcome Trust Conference Centre, Cambridge, UK at 4pm (BST) on Tuesday, 30th March 2010.

The presentation will provide an insight into how Apitope designs and develops therapeutic peptides for revolutionary treatment of autoimmune diseases and allergies.

The conference will feature leading researchers and experts from the various fields of peptide therapeutics development, presenting the latest scientific and technological knowledge in these rapidly advancing areas of life sciences. The applications of peptide chemistry from synthesis through purification and analytics,bioactivity testing in biotechnology, biomedical and other applications from nalytical to industrial scales will be presented.